Achieving a complete remission by FDG-PET pre-ASCT is the most important prognostic factor in obtaining disease control and subsequent cure, and therefore should be a key goal of any salvage regimen. Although data from randomized controlled trials are currently lacking, retrospective evidence demonstrate superior event free survival with CPI-based regimens compared to conventional chemotherapy or BV-based therapy.
Keyphrases
- hodgkin lymphoma
- free survival
- prognostic factors
- pet ct
- positron emission tomography
- pet imaging
- randomized controlled trial
- computed tomography
- electronic health record
- current status
- lipopolysaccharide induced
- cross sectional
- lps induced
- big data
- disease activity
- stem cells
- squamous cell carcinoma
- clinical trial
- rheumatoid arthritis
- inflammatory response
- systemic lupus erythematosus
- bone marrow
- study protocol
- artificial intelligence
- data analysis
- cell therapy
- smoking cessation